ODI PHARMA AB |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.55 SEK | +1.34% |
|
+4.14% | +51.00% |
| 05-30 | ODI Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
| 05-02 | ODI Pharma AB Provides Sales Guidance for the Third Quarter of the Year 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 10.9M | - | - | - | - | - | |
| 765B | ||||||
| 354B | - | - | - | - | ||
| 331B | ||||||
| 299B | ||||||
| 248B |
- Stock Market
- Equities
- ODI Stock
- Charts ODI Pharma AB
- Sector Chart